A group image from the second Aniridia Europe's conference in Venice in 2014

Aniridia Europe gathers people all over the continent


We want to support people with aniridia in all countries and help them to share information and build useful networks in their own countries and abroad.


In Your Country

What's newDonate

What is Aniridia?

Aniridia is a very rare disease and every family affected is often alone to face the diagnosis. Even nationally, there’s often only a small group of individuals. Get to know aniridia.

Aniridia Europe, the federation of European aniridia associations and representatives, has been founded to change this situation. Read our mission objectives.

As of September 2021, the federation includes 13 national associations, as well as support groups and contact persons in 20 other European countries.
Get in touch with someone in your country.

An image of two girls with aniridia smiling on Summer Camp
A image of a group of young people with aniridia from Summer Camp in 2015
A portrait image of a girl with aniridia
An image of a young girl with aniridia who smiling in front of the camera

News & Events

The 6th European Aniridia Conference announced!

The Spanish Aniridia Association, with the collaboration of Aniridia Europe, Cost Action and Vissum-Miranza Ophthalmology Clinic, invites you to attend the 6th European Aniridia Conference, that will take place on June 3-5th 2022 in San Juan de Alicante, Spain. A...

Learn more

News from Aniridia Europe, January 2022

Dear friends, this year has been very challenging for all the world, and even more challenging for people, like us, that face difficulties every day in their lives. But one lesson we have learned during these years: together we are stronger, together we can better...

Learn more

Updates about the AAK-INSIGHT project

Professor Daniel Aberdam (INSERM, Paris, France) has kindly sent the figure you find below to summarize the effort of his team together with other groups of scientists to identify and validate small compounds that could become novel therapeutic tools to treat...

Learn more